title: The treatment of advanced non-small-cell lung cancer (NSCLC)--overseas updated and local experiences.
authors.affiliation: Cancer Institute and Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100021.
authors.forename: Da-Tong
authors.initials: DT
authors.lastname: Chu
authors.forename: Xiang-Ru
authors.initials: XR
authors.lastname: Zhang
authors.forename: Jun-Ling
authors.initials: JL
authors.lastname: Li
authors.forename: Feng-Lian
authors.initials: FL
authors.lastname: Qu
authors.forename: Yan
authors.initials: Y
authors.lastname: Sun
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality; D002945:Cisplatin / Q000008:administration & dosage; D017326:Clinical Trials, Phase III as Topic; D015251:Epirubicin / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D016685:Mitomycin / Q000008:administration & dosage; D015996:Survival Rate
chemical_list: D015251:Epirubicin; D016685:Mitomycin; D002945:Cisplatin; D007069:Ifosfamide